{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:59:19Z","timestamp":1790949559627,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12890-017-0479-2","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T14:49:37Z","timestamp":1508856577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias"],"prefix":"10.1186","volume":"17","author":[{"given":"Hiroko","family":"Okabayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Ichiyasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Hirooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimitaka","family":"Akaike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Jodai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumiko","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideharu","family":"Ideguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Hirosako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Kohrogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"479_CR1","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","volume":"63","author":"I Marie","year":"2011","unstructured":"Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum. 2011;63:3439\u201347.","journal-title":"Arthritis Rheum"},{"key":"479_CR2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/BOR.0b013e32833f1987","volume":"22","author":"S Sato","year":"2010","unstructured":"Sato S, Kuwana M. Clinically amyopathic dermatomyositis. Curr Opin Rheumatol. 2010;22:639\u201343.","journal-title":"Curr Opin Rheumatol"},{"key":"479_CR3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","volume":"23","author":"S Sato","year":"2013","unstructured":"Sato S, Kuwana M, Fujita T, Suzuki Y. Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol. 2013;23:496\u2013502.","journal-title":"Mod Rheumatol"},{"key":"479_CR4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, Kawaguchi Y, Satoh T, Kuwana M, Katsumuta Y, Takagi K, et al. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology. 2010;49:1713\u20139.","journal-title":"Rheumatology"},{"key":"479_CR5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjd.14882","volume":"176","author":"T Matsushita","year":"2017","unstructured":"Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, et al. Anti-MDA5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br J Dermatol. 2017;176:395\u2013402.","journal-title":"Br J Dermatol"},{"key":"479_CR6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-9610(94)90126-0","volume":"167","author":"H Aoki","year":"1994","unstructured":"Aoki H, Kodama M, Tani T, Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg. 1994;167:412\u20137.","journal-title":"Am J Surg"},{"key":"479_CR7","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","volume":"301","author":"DN Cruz","year":"2009","unstructured":"Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009;301:2445\u201352.","journal-title":"JAMA"},{"key":"479_CR8","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1186\/cc13912","volume":"18","author":"C Ronco","year":"2014","unstructured":"Ronco C, Klein DJ. Polymyxin B hemoperfusion: a mechanistic perspective. Crit Care. 2014;18:e309.","journal-title":"Crit Care"},{"key":"479_CR9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/cc3815","volume":"9","author":"H Kushi","year":"2005","unstructured":"Kushi H, Miki T, Okamaoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care. 2005;9:653\u201361.","journal-title":"Crit Care"},{"key":"479_CR10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1744-9987.2007.00415.x","volume":"11","author":"K Tsushima","year":"2007","unstructured":"Tsushima K, Kubo K, Yoshikawa S, Koizumi T, Yasuo M, Furuya S, et al. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome. Ther Apher Dial. 2007;11:138\u201345.","journal-title":"Ther Apher Dial"},{"key":"479_CR11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.amjsurg.2003.12.067","volume":"188","author":"S Ono","year":"2004","unstructured":"Ono S, Tsujimoto H, Matsumoto A, Ikuta S, Kinoshita M, Mochizuki H. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Am J Surg. 2004;188:150\u20136.","journal-title":"Am J Surg"},{"key":"479_CR12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2169\/internalmedicine.45.6018","volume":"45","author":"Y Seo","year":"2006","unstructured":"Seo Y, Abe S, Kurahara M, Okada D, Saito Y, Usuki J, et al. Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis. Intern Med. 2006;45:1033\u20138.","journal-title":"Intern Med"},{"key":"479_CR13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000321958","volume":"81","author":"S Hara","year":"2011","unstructured":"Hara S, Ishimoto H, Sakamoto N, Mukae H, Kakugawa T, Ishimatsu Y, et al. Direct hemoperfusion using immobilized polymyxin B in patients with rapidly progressive interstitial pneumonias: a retrospective study. Respiration. 2011;81:107\u201317.","journal-title":"Respiration"},{"key":"479_CR14","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1378\/chest.12-0994","volume":"143","author":"N Sato","year":"2013","unstructured":"Sato N, Kojima K, Horio Y, Goto E, Masunaga A, Ichiyasu H, et al. Successful treatment of severe amiodarone pulmonary toxicity with polymyxin B-immobilized fiber column direct hemoperfusion. Chest. 2013;143:1146\u201350.","journal-title":"Chest"},{"key":"479_CR15","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2169\/internalmedicine.51.6965","volume":"51","author":"S Abe","year":"2012","unstructured":"Abe S, Azuma A, Mukae H, Ogura T, Taniguchi H, Bando M, et al. Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis. Intern Med. 2012;51:1487\u201391.","journal-title":"Intern Med"},{"key":"479_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12890-015-0004-4","volume":"e15","author":"N Enomoto","year":"2015","unstructured":"Enomoto N, Mikamo M, Oyama Y, Kono M, Hashimoto D, Fujisawa T, et al. Treatment of acute exacerbation of idiopathic pulmonary fibrosis with direct hemoperfusion using a polymyxin B-immobilized fiber column improves survival. BMC Pulm Med. 2015;e15:15.","journal-title":"BMC Pulm Med."},{"key":"479_CR17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1753465817708950","volume":"11","author":"H Ichiyasu","year":"2017","unstructured":"Ichiyasu H, Horio Y, Masunaga A, Migiyama Y, Sakamoto Y, Jodai T, et al. Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a historical control study and a review of previous studies. Ther Adv Respir Dis. 2017;11:261\u201375.","journal-title":"Ther Adv Respir Dis"},{"key":"479_CR18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000287232","volume":"29","author":"S Abe","year":"2010","unstructured":"Abe S, Seo Y, Hayashi H, Matsuda K, Usuki J, Azuma A, et al. Neutrophil adsorption by polymyxin B-immobilized fiber column for acute exacerbation in patients with interstitial pneumonia: a pilot study. Blood Purif. 2010;29:321\u20136.","journal-title":"Blood Purif"},{"key":"479_CR19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000330325","volume":"32","author":"S Abe","year":"2011","unstructured":"Abe S, Hayashi H, Seo Y, Matsuda K, Kamio K, Saito Y, et al. Reduction in serum high mobility group box-1 level by polymyxin B-immobilized fiber column in patients with idiopathic pulmonary fibrosis with acute exacerbation. Blood Purif. 2011;32:310\u20136.","journal-title":"Blood Purif"},{"key":"479_CR20","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.4049\/jimmunol.165.6.2950","volume":"165","author":"E Abraham","year":"2000","unstructured":"Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. Cutting edge:HMGB-1 as a mediator of acute lung inflammation. J Immunol. 2000;165:2950\u20134.","journal-title":"J Immunol"},{"key":"479_CR21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/14397595.2013.852847","volume":"24","author":"H Ichiyasu","year":"2014","unstructured":"Ichiyasu H, Horio Y, Tsumura S, Hirosako S, Sakamoto Y, Sakata S, et al. Favorable outcome with hemoperfusion of polymyxin B-immobilized fiber column for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of three cases. Mod Rheumatol. 2014;24:361\u20135.","journal-title":"Mod Rheumatol"},{"key":"479_CR22","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1378\/chest.13-0186","volume":"144","author":"A Teruya","year":"2013","unstructured":"Teruya A, Kawamura K, Ichikado K, Sato S, Yasuda Y, Yoshioka M. Successful polymyxin B hemoperfusion treatment associated with serial reduction of serum anti-CADM-140\/MDA5 antibody levels in rapidly progressive interstitial lung disease with amyopathic dermatomyositis. Chest. 2013;144:1934\u20136.","journal-title":"Chest"},{"key":"479_CR23","doi-asserted-by":"crossref","first-page":"750275","DOI":"10.1155\/2013\/750275","volume":"2013","author":"O Sasaki","year":"2013","unstructured":"Sasaki O, Dohi M, Harada H, Inamura M, Tsuchida Y, Yamaguchi K, et al. A case of polymyxin b-immobilized fiber column treatment for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis. Case Rep Med. 2013;2013:750275.","journal-title":"Case Rep Med"},{"key":"479_CR24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2169\/internalmedicine.47.0639","volume":"47","author":"T Kakugawa","year":"2008","unstructured":"Kakugawa T, Mukae H, Saito M, Ishii K, Ishimoto H, Sakamoto N, et al. Rapidly progressive interstitial pneumonia associated with clinically amyopathic dermamyositis successfully treated with polymyxin B-immobilized fiber column hemoperfusion. Intern Med. 2008;47:785\u201390.","journal-title":"Intern Med"},{"key":"479_CR25","first-page":"51","volume":"20","author":"H Ichiyasu","year":"2017","unstructured":"Ichiyasu H, Sakamoto Y, Yoshida C, Sakamoto K, Fujita R, Nakayama G, et al. Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy. Respir Med Case Rep. 2017;20:51\u20134.","journal-title":"Respir Med Case Rep"},{"key":"479_CR26","doi-asserted-by":"crossref","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344\u2013348.","DOI":"10.1056\/NEJM197502132920706"},{"key":"479_CR27","doi-asserted-by":"crossref","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403\u2013407.","DOI":"10.1056\/NEJM197502202920807"},{"key":"479_CR28","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626\u201336.","journal-title":"J Am Acad Dermatol"},{"key":"479_CR29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0733-8635(02)00021-9","volume":"20","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin. 2002;20:387\u2013408.","journal-title":"Dermatol Clin"},{"key":"479_CR30","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1164\/rccm.2106157","volume":"165","author":"K Ichikado","year":"2002","unstructured":"Ichikado K, Suga M, Nestor L. M\u00fcller, Taniguchi H, Kondoh Y, et al. acute interstitial pneumonia comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med. 2002;165:1551\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"479_CR31","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","volume":"342","author":"RG Brower","year":"2000","unstructured":"Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301\u20138.","journal-title":"N Engl J Med"},{"key":"479_CR32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.299.6.637","volume":"299","author":"MO Meade","year":"2008","unstructured":"Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299:637\u201345.","journal-title":"JAMA"},{"key":"479_CR33","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/rheumatology\/keq073","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, Kawaguchi Y, Hara M, Masuda I, Katsumata Y, Shinozaki M, et al. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). 2010;49:1354\u201360.","journal-title":"Rheumatology (Oxford)"},{"key":"479_CR34","doi-asserted-by":"crossref","first-page":"e89610","DOI":"10.1371\/journal.pone.0089610","volume":"9","author":"K Isoda","year":"2014","unstructured":"Isoda K, Takeuchi T, Kotani T, Hata K, Shoda T, Ishida T, et al. Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute\/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a\/ glucocorticosteroid combination therapy: a case control study. PLoS One. 2014;9:e89610.","journal-title":"PLoS One"},{"key":"479_CR35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cyto.2012.08.032","volume":"61","author":"K Oishi","year":"2013","unstructured":"Oishi K, Mimura-Kimura Y, Miyasho T, Aoe K, Ogata Y, Katayama H, et al. Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis. Cytokine. 2013;61:84\u20139.","journal-title":"Cytokine"},{"key":"479_CR36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11926-012-0246-6","volume":"14","author":"T Mimori","year":"2012","unstructured":"Mimori T, Nakashima R, Hosono Y. Interstitial lung disease in Myositis:clinical subsets, biomarkers, and treatment. Curr Rheumatol Rep. 2012;14:264\u201374.","journal-title":"Curr Rheumatol Rep"},{"key":"479_CR37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.yexmp.2007.08.005","volume":"83","author":"RV Mandel","year":"2007","unstructured":"Mandel RV, Mark EJ, Kradin RL. Megakaryocytes and platelet homeostasis in diffuse alveolar damage. Exp Mol Pathol. 2007;83:327\u201331.","journal-title":"Exp Mol Pathol"},{"key":"479_CR38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1165\/rcmb.2008-0241TR","volume":"40","author":"FA Bozza","year":"2009","unstructured":"Bozza FA, Shah AM, Weyrich AS, Zimmerman GA. Amicus or adversary platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol. 2009;40:123\u201334.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"479_CR39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12890-015-0154-4","volume":"15","author":"S Ikeda","year":"2015","unstructured":"Ikeda S, Arita M, Morita M, Ikeo S, Ito A, Tokioka F, et al. Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split? BMC Pulm Med. 2015;15:159.","journal-title":"BMC Pulm Med"},{"key":"479_CR40","doi-asserted-by":"crossref","first-page":"e0161436","DOI":"10.1371\/journal.pone.0161436","volume":"11","author":"X Shu","year":"2016","unstructured":"Shu X, Peng Q, Lu X, Wang G. HMGB-1 may be a biomarker for predicting the outcome in patients with polymyositis\/dermatomyositis with interstitial lung disease. PLoS One. 2016;11:e0161436.","journal-title":"PLoS One"},{"key":"479_CR41","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2169\/internalmedicine.53.2687","volume":"53","author":"T Takada","year":"2014","unstructured":"Takada T, Asakawa K, Sakagami T, Moriyama H, Kazama J, Suzuki E, et al. Effects of direct hemoperfusion with polymyxin B-immobilized fiber on rapidly progressive interstitial lung disease. Intern Med. 2014;53:1921\u20136.","journal-title":"Intern Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-017-0479-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T14:49:51Z","timestamp":1508856591000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-017-0479-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1186\/s12890-017-0479-2","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]},"article-number":"134"}}